Global Markets Direct’s, “Malaria – Pipeline Review, Q1 2011,” provides an overview of the Malaria therapeutic pipeline.

This report provides information on the therapeutic development for Malaria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malaria. “Malaria – Pipeline Review, Q1 2011” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

via Malaria – Pipeline Review, Q1 2011 – Market Research Reports.